Faraday Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on preventing heart failure by reducing myocardial damage in acute ST-elevation myocardial infarction (STEMI) through ...

A new study reveals that heart attack survivors could greatly reduce their risk of a second event by starting combination ...

Ten years after learning their polygenic risk score, patients had fewer events—perhaps due to greater use of statin therapy.

Not everyone is sold on the benefits of early ezetimibe use, especially given the modest effect seen in IMPROVE-IT.

The molecular mechanism behind why heart attacks can vary in severity depending on the time of day has been uncovered, potentially paving the way for innovative treatments that align with the natural ...

The molecular mechanism behind why heart attacks can vary in severity depending on the time of day has been uncovered by ...

ST-elevated myocardial infarction more accurately than a clinician in an emergency department, which might upend standard ...

Patients with COPD and established cardiovascular disease have more MACEs and seek less preventive cardiac care than patients with CVD alone.

Adverse cardiovascular outcomes can be predicted in patients with coronary artery disease with a risk score that includes mental stress outcomes.

BACKGROUND: High-volume physical activity (PA) is associated with a higher prevalence of subclinical coronary artery disease ...

Article The risk of severe complications after myocardial infarction has decreased, but the quality of life will not be the same as before. The incidence of myocardial infarction in Norway has ...

A study has found that moderate-to-severe obstructive sleep apnea increases risk for incident myocardial infarction between 12 and 5:59 AM.